doi: 10.1161/01.ATV.0000151931.91737.00
© 2005 American Heart Association, Inc.
Editorials |
Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
Correspondence to Donald D. Heistad, MD, ATVB Editorial Office, 609 MRC, Cardiovascular Unit, The University of Iowa, Iowa City, IA 52242. Email atvb@uiowa.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
The purpose of this editorial is to provide for our readers the annual update of the status of the journal. Goals of our editorship, which began in 1999, were to publish high-quality papers, provide authors with timely review and publication of their manuscripts, and to publish papers of interest to our readers. We will summarize data related to each of these goals, some changes and plans for the journal, and thank several people for their help.
Publication of High-Quality Papers
There is no perfect approach to evaluate journals and the quality of papers published in journals. Impact factor is one measure of quality of papers. In some Universities, decisions about promotion and tenure are based in part on impact factor of journals in which papers are published. Thus, impact factor may be important, in relation to selection of journals in which authors wish to publish their work.
The impact factor for ATVB again increased this past year, to 6.8 (Figure 1). The impact factor of the journal has increased more than 70% during the past few years. The large increase in 1999 was determined by decisions during the editorship of Dr Alan Fogelman. Impact factors of other journals in this area of research have not changed consistently during the last few years (Figure 1). We believe that Arteriosclerosis, Thrombosis, and Vascular Biology is recognized as an appropriate forum for publication of excellent papers related to atherosclerosis, lipoproteins, vascular biology, and thrombosis.
| |||||||||||
